发明名称 2-oksybenzoksazinonderivater for behandling av fedme
摘要 The use of a compound comprising formula (I): or a salt, ester, amide or prodrug thereof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The compounds are also useful in medicine e.g. in the treatment of obesity and related conditions. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I) A is a 6-membered aromatic or heteroaromatic ring; and R1 is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or a substituted derivative of any of the foregoing groups.
申请公布号 NO20013381(D0) 申请公布日期 2001.07.06
申请号 NO20010003381 申请日期 2001.07.06
申请人 ALIZYME THERAPEUTICS LTD 发明人 HODSON, HAROLD FRANCIS;DOWNHAM, ROBERT;MITCHELL, TIMOTHY JOHN;CARR, BEVERLEY JANE;DUNK, CHRISTOPHER ROBERT;PALMER, RICHARD MICHAEL JOHN
分类号 C07D265/18;A61K8/00;A61K8/49;A61K31/536;A61P1/00;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/12;A61P25/00;A61P43/00;A61Q19/10;C07C271/28;C07D265/24;C07D265/26;C07D413/12;C07D498/04;(IPC1-7):A61K 主分类号 C07D265/18
代理机构 代理人
主权项
地址